VMD - Viemed Healthcare Inc Stock Price, Fair Value and News

8.09USD+0.03 (+0.37%)Market Closed

Market Summary

USD8.09+0.03

Market Closed

0.37%

VMD Stock Price

View Fullscreen

VMD RSI Chart

VMD Valuation

Market Cap

312.4M

Price/Earnings (Trailing)

30.5

Price/Sales (Trailing)

1.71

EV/EBITDA

18.37

Price/Free Cashflow

16.34

VMD Price/Sales (Trailing)

VMD Profitability

EBT Margin

7.86%

Return on Equity

8.99%

Return on Assets

6.61%

Free Cashflow Yield

6.12%

VMD Fundamentals

VMD Revenue

Revenue (TTM)

183.0M

Rev. Growth (Yr)

35.28%

Rev. Growth (Qtr)

2.71%

VMD Earnings

Earnings (TTM)

10.2M

Earnings Growth (Yr)

42.62%

Earnings Growth (Qtr)

19.12%

Breaking Down VMD Revenue

Last 7 days

-2.5%

Last 30 days

-12.0%

Last 90 days

-3.6%

Trailing 12 Months

-30.5%

How does VMD drawdown profile look like?

VMD Financial Health

Current Ratio

1.19

Debt/Equity

0.05

Debt/Cashflow

7.53

VMD Investor Care

Shares Dilution (1Y)

1.54%

Diluted EPS (TTM)

0.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	146.1M	156.1M	169.8M	183.0M
2022	120.9M	126.8M	133.3M	138.8M
2021	135.9M	120.5M	116.3M	117.1M
2020	85.9M	108.5M	121.6M	131.3M
2019	68.6M	73.7M	77.2M	80.3M
2018	0	0	0	64.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Viemed Healthcare Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 22, 2024	hoyt casey	gifted	-	-	-26,000	chief executive officer
Jan 18, 2024	hoyt casey	back to issuer	-107,549	7.62	-14,114	chief executive officer
Jan 18, 2024	hoyt casey	acquired	-	-	28,228	chief executive officer
Jan 18, 2024	cambre jerome	back to issuer	-22,882	7.62	-3,003	vice president of sales
Jan 18, 2024	hoyt casey	acquired	-	-	14,114	chief executive officer
Jan 18, 2024	fitzgerald trae	acquired	-	-	5,406	chief financial officer
Jan 18, 2024	zehnder william todd	acquired	-	-	9,490	chief operating officer
Jan 18, 2024	moore michael	acquired	-	-	18,979	president
Jan 18, 2024	zehnder william todd	back to issuer	-72,313	7.62	-9,490	chief operating officer
Jan 18, 2024	moore michael	acquired	-	-	9,490	president

Which funds bought or sold VMD recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	Spartan Fund Management Inc.	added	16.68	394,844	1,377,980	2.82%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.18	-27,000	11,000	-%
Apr 22, 2024	MetLife Investment Management, LLC	unchanged	-	20,273	142,093	-%
Apr 18, 2024	Penbrook Management LLC	reduced	-1.22	102,248	650,076	0.40%
Apr 18, 2024	WASATCH ADVISORS LP	unchanged	-	1,837,440	10,966,500	0.06%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	-	1,000	-%
Apr 15, 2024	Legato Capital Management LLC	unchanged	-	156,314	932,938	0.11%
Apr 12, 2024	Pacifica Partners Inc.	unchanged	-	485	3,398	-%
Apr 11, 2024	SALEM INVESTMENT COUNSELORS INC	added	118	420,628	679,027	0.02%
Apr 05, 2024	CWM, LLC	new	-	-	-	-%

Are Funds Buying or Selling VMD?

Are funds buying VMD calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VMD

No. of Funds

Unveiling Viemed Healthcare Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 15, 2024	hoyt casey	8.0%	3,116,189	SC 13G/A
Feb 15, 2024	moore michael	6.5%	2,520,918	SC 13D/A
Feb 14, 2024	nantahala capital management, llc	5.1%	1,952,368	SC 13G
Feb 13, 2024	thrivent financial for lutherans	8.7%	3,347,784	SC 13G/A
Feb 02, 2024	blackrock inc.	5.6%	2,129,167	SC 13G
May 18, 2023	moore michael	6.3%	2,421,319	SC 13D/A
Feb 21, 2023	viemed healthcare, inc.	7.6%	2,973,243	SC 13G/A
Feb 08, 2023	thrivent financial for lutherans	10.88%	4,134,751	SC 13G/A
Oct 18, 2022	thrivent financial for lutherans	10.1%	3,855,125	SC 13G/A
Jul 08, 2022	blackrock inc.	2.4%	967,193	SC 13G

Recent SEC filings of Viemed Healthcare Inc

View All Filings

Date Filed	Form Type	Document
Apr 02, 2024	8-K	Current Report
Mar 25, 2024	4	Insider Trading
Mar 11, 2024	8-K	Current Report
Mar 06, 2024	10-K	Annual Report
Mar 06, 2024	8-K	Current Report
Feb 15, 2024	SC 13D/A	13D - Major Acquisition
Feb 15, 2024	SC 13G/A	Major Ownership Report
Feb 14, 2024	SC 13G	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report
Feb 02, 2024	SC 13G	Major Ownership Report

Peers (Alternatives to Viemed Healthcare Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.7B	40.1B	-2.69%	-2.54%	32.62	4.65	-8.12%	-17.45%
BDX	67.7B	19.5B	-4.86%	-10.59%	53.89	3.47	4.02%	-22.04%
ALGN	23.4B	3.9B	-2.36%	-14.10%	52.63	6.06	3.42%	23.09%
BAX	20.8B	14.8B	-2.22%	-9.67%	7.84	1.41	2.12%	209.17%
MID-CAP
HSIC	9.4B	12.3B	-0.49%	-14.47%	22.48	0.76	-2.44%	-22.68%
ATR	9.3B	3.5B	-1.02%	16.40%	32.52	2.65	4.97%	18.89%
BIO	8.3B	2.7B	-18.63%	-38.25%	-13.07	3.12	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.77%	-25.53%	-47.58	1.61	1.10%	85.84%
AXNX	3.4B	366.4M	-2.62%	10.65%	-558.61	9.25	33.86%	89.83%
PDCO	2.3B	6.6B	-4.73%	-4.84%	12.02	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-11.22%	-19.13%	-1.92	0.41	7.73%	-1066.14%
ANIK	383.0M	166.7M	1.30%	-3.37%	-4.63	2.3	6.67%	-456.34%
ANGO	241.5M	324.0M	12.50%	-31.24%	-1.26	0.75	-3.19%	-337.41%
APYX	45.7M	52.3M	5.60%	-56.15%	-2.44	0.87	17.61%	19.28%
AEMD	4.0M	3.7M	-11.70%	184.91%	-0.32	1.06	5.77%	8.23%

Viemed Healthcare Inc News

Latest updates

Viemed Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	2.7%	50,739	49,402	43,311	39,556	37,508	35,759	33,310	32,255	31,962	29,285	27,399	28,416	31,202	33,447	42,854	23,806	21,448	20,368	20,325	18,115	18,363
Gross Profit	5.1%	32,111	30,562	26,106	24,004	22,896	21,651	20,390	19,743	19,662	18,381	17,625	17,742	19,178	19,453	25,927	15,553	14,243	14,050	14,639	13,074	13,519
S&GA Expenses	1.1%	23,905	23,654	20,563	19,762	17,172	17,677	17,536	15,776	14,240	13,260	12,884	14,509	12,274	13,550	16,428	10,577	10,174	10,231	11,516	9,460	9,696
R&D Expenses	9.8%	651	593	758	780	722	670	672	632	612	576	583	339	395	243	271	174	203	208	203	234	-
EBITDA Margin	-54.3%	0.09*	0.20*	0.19*	0.18*	0.18*	0.19*	0.20*	0.21*	0.21*	0.21*	0.20*	0.25*	-	-	-	-	-	-	-	-	-
Interest Expenses	7.9%	354	328	127	42.00	46.00	57.00	62.00	66.00	73.00	80.00	81.00	117	122	128	144	165	242	39.00	26.00	26.00	-
Income Taxes	23.0%	1,624	1,320	728	500	1,146	456	421	745	968	1,386	1,246	-223	151	1,141	-6,646	187	58.00	51.00	24.00	138	127
Earnings Before Taxes	19.7%	5,076	4,239	3,058	2,018	3,584	1,511	1,388	2,507	5,055	3,175	2,812	1,461	5,222	3,945	12,766	4,430	2,446	2,904	1,350	2,096	3,095
EBT Margin	3.5%	0.08*	0.08*	0.07*	0.06*	0.06*	0.08*	0.10*	0.11*	0.11*	0.11*	0.11*	0.17*	-	-	-	-	-	-	-	-	-
Net Income	19.1%	3,477	2,919	2,330	1,517	2,438	1,055	967	1,762	4,087	1,789	1,566	1,684	5,071	2,804	19,412	4,243	2,388	2,853	1,326	1,958	2,968
Net Income Margin	3.2%	0.06*	0.05*	0.05*	0.04*	0.04*	0.06*	0.07*	0.08*	0.08*	0.09*	0.09*	0.21*	-	-	-	-	-	-	-	-	-
Free Cashflow	-16.5%	5,352	6,407	1,545	5,815	2,112	1,635	-2,080	3,183	1,992	-3,005	933	2,831	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	3.7%	155	149	149	125	117	119	116	119	118	115	111	113	113	114	112	87.00	83.00	80.00	71.00	59.00	54.00
Current Assets	7.0%	38.00	36.00	36.00	47.00	40.00	43.00	42.00	48.00	47.00	47.00	47.00	48.00	47.00	50.00	49.00	30.00	28.00	28.00	25.00	24.00	23.00
Cash Equivalents	27.4%	13.00	10.00	10.00	24.00	17.00	21.00	22.00	29.00	28.00	27.00	31.00	31.00	31.00	32.00	30.00	8.00	13.00	13.00	8.00	7.00	10.00
Inventory	-0.9%	5.00	5.00	4.00	3.00	4.00	3.00	3.00	3.00	2.00	3.00	3.00	2.00	2.00	3.00	7.00	2.00	1.00	1.00	4.00	4.00	3.00
Net PPE	0.2%	74.00	73.00	73.00	68.00	68.00	-	-	64.00	63.00	59.00	54.00	54.00	55.00	56.00	55.00	57.00	55.00	52.00	46.00	35.00	31.00
Goodwill	0.2%	30.00	30.00	30.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liabilities	1.0%	41.00	41.00	45.00	25.00	20.00	26.00	23.00	23.00	23.00	26.00	25.00	30.00	31.00	39.00	41.00	38.00	39.00	40.00	35.00	25.00	21.00
Current Liabilities	1.8%	32.00	32.00	32.00	23.00	19.00	21.00	18.00	18.00	18.00	20.00	18.00	22.00	23.00	30.00	32.00	26.00	26.00	27.00	27.00	22.00	20.00
Long Term Debt	-25.9%	6.00	8.00	12.00	-	-	4.00	4.00	4.00	4.00	4.00	5.00	5.00	6.00	6.00	7.00	7.00	8.00	8.00	5.00	-	-
LT Debt, Current	-41.5%	1.00	2.00	3.00	-	-	0.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	0.00	-	-
LT Debt, Non Current	-25.9%	6.00	8.00	12.00	-	-	4.00	4.00	4.00	4.00	4.00	5.00	5.00	6.00	6.00	7.00	7.00	8.00	8.00	5.00	-	-
Shareholder's Equity	4.7%	114	109	105	100	97.00	94.00	93.00	96.00	95.00	89.00	86.00	83.00	82.00	75.00	71.00	49.00	44.00	40.00	36.00	34.00	33.00
Retained Earnings	4.6%	79.00	76.00	73.00	71.00	70.00	68.00	69.00	73.00	73.00	69.00	67.00	66.00	66.00	61.00	58.00	38.00	34.00	32.00	29.00	28.00	27.00
Additional Paid-In Capital	10.8%	16.00	14.00	13.00	12.00	12.00	11.00	10.00	9.00	8.00	7.00	5.00	4.00	7.00	6.00	5.00	4.00	6.00	5.00	5.00	4.00	5.00
Shares Outstanding	0.0%	39.00	38.00	38.00	38.00	38.00	39.00	39.00	40.00	39.00	40.00	39.00	39.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	330	-	-	-	182	-	-	-	251	-	-	-	335	-	-	-	117,224	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-3.8%	13,284	13,809	7,623	10,496	7,684	7,972	4,946	7,146	8,655	5,028	4,183	4,628	5,791	7,331	21,381	607	7,400	5,724	5,313	650	-
Share Based Compensation	5.6%	1,534	1,453	1,471	1,391	1,317	1,309	1,271	1,305	1,305	1,302	1,236	1,307	1,301	1,234	1,196	1,151	908	1,064	1,034	880	804
Cashflow From Investing	11.9%	-7,493	-8,508	-32,207	-3,905	-7,378	-6,103	-6,688	-3,807	-6,563	-8,425	-3,060	-1,698	-5,368	-2,427	1,091	-1,711	-2,579	-2,745	-7,395	-92.00	-
Cashflow From Financing	44.4%	-3,030	-5,447	11,264	39.00	-4,870	-2,313	-5,584	-2,499	-551	-887	-1,069	-2,814	-1,838	-2,215	-1,174	-3,842	-4,096	1,960	2,363	-3,561	-
Buy Backs	-	-	-	-	-	710	1,857	5,114	1,887	-	-	-1,434	1,434	-	-	-	-	-	-	-	1,522	-

VMD Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 183,008	$ 138,832
Cost of revenue	70,225	54,152
Gross profit	112,783	84,680
Operating expenses
Selling, general and administrative	87,884	68,161
Research and development	2,782	2,696
Stock-based compensation	5,849	5,202
Depreciation and amortization	1,391	1,012
Loss on disposal of property and equipment	645	346
Other income, net	(98)	(989)
Income from operations	14,330	8,252
Non-operating income and expenses
Income from equity method investments	485	935
Interest expense, net	(424)	(197)
Net income before taxes	14,391	8,990
Provision for income taxes	4,148	2,768
Net income	10,243	6,222
Other comprehensive income
Change in unrealized gain/loss on derivative instruments, net of tax	0	278
Other comprehensive income	0	278
Comprehensive income	$ 10,243	$ 6,500
Net income per share
Basic (in dollars per share)	$ 0.27	$ 0.16
Diluted (in dollars per share)	$ 0.25	$ 0.16
Weighted average number of common shares outstanding:
Basic (in shares)	38,354,071	38,655,403
Diluted (in shares)	40,378,922	39,807,434

VMD Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 12,839	$ 16,914
Accounts receivable, net	18,451	15,379
Inventory	4,628	3,574
Income tax receivable	0	26
Prepaid expenses and other assets	2,449	3,849
Total current assets	38,367	39,742
Long-term assets
Property and equipment, net	73,579	67,743
Finance lease right-of-use assets	401	0
Operating lease right-of-use assets	2,872	694
Equity investments	1,680	2,155
Debt investment	2,219	2,000
Deferred tax asset	4,558	3,119
Identifiable intangibles, net	567	0
Goodwill	29,765	0
Other long-term assets	887	1,590
Total long-term assets	116,528	77,301
TOTAL ASSETS	154,895	117,043
Current liabilities
Trade payables	4,180	2,650
Deferred revenue	6,207	4,624
Income taxes payable	2,153	0
Accrued liabilities	17,578	11,092
Finance lease liabilities, current portion	256	0
Operating lease liabilities, current portion	678	495
Current debt	1,072	0
Total current liabilities	32,124	18,861
Long-term liabilities
Accrued liabilities	558	889
Finance lease liabilities, less current portion	132	0
Operating lease liabilities, less current portion	2,184	199
Long-term debt	6,002	0
Total long-term liabilities	8,876	1,088
TOTAL LIABILITIES	41,000	19,949
Commitments and Contingencies	0	0
SHAREHOLDERS' EQUITY
Common stock - No par value: unlimited authorized; 38,506,161 and 38,049,739 issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	18,702	15,123
Additional paid-in capital	15,698	12,125
Retained earnings	79,495	69,846
TOTAL SHAREHOLDERS' EQUITY	113,895	97,094
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 154,895	$ 117,043

About Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

CEO	Mr. Casey Hoyt
WEBSITE	viemed.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	974

Viemed Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Viemed Healthcare Inc? What does VMD stand for in stocks?

VMD is the stock ticker symbol of Viemed Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Viemed Healthcare Inc (VMD)?

As of Tue Apr 23 2024, market cap of Viemed Healthcare Inc is 312.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers. The fair value of Viemed Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Viemed Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Viemed Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether VMD is over valued or under valued. Whether Viemed Healthcare Inc is cheap or expensive depends on the assumptions which impact Viemed Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VMD.

What is Viemed Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, VMD's PE ratio (Price to Earnings) is 30.5 and Price to Sales (PS) ratio is 1.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VMD PE ratio will change depending on the future growth rate expectations of investors.